Brief: Virpax Pharmaceuticals Says Remain On Track To File IND For Envelta By Q2 Of 2024
05/04/2023 14:33
April 5 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS - REMAIN ON TRACK TO FILE IND FOR
ENVELTA
BY Q2 OF 2024
Source text for Eikon: urn:newsml:reuters.com:*:nBwzqxBTa
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study